ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.790
+0.070 (1.48%)
At close: Jul 6, 2026, 4:00 PM EDT
4.880
+0.090 (1.88%)
After-hours: Jul 6, 2026, 5:39 PM EDT
ENDRA Life Sciences Earnings Call Transcripts
Fiscal Year 2024
-
Q2 2024 saw a $7.3M capital raise, 26% cut in operating expenses, and a strategic shift toward primary care and endocrinology for the TAEUS liver device. FDA submission is targeted for mid-2025, with a strengthened management team and expanded patent portfolio.